1-3 of 3
Rikio Suzuki, MD
Close
Sort by
Journal Articles

CD56 Is an Unfavorable Prognostic Factor for Acute Promyelocytic Leukemia: Results By Multivariate Analyses in the JALSG-APL204 Study

Akihiro Takeshita, MDPhD, Norio Asou, MD PhD, Yoshiko Atsuta, MD PhD, Hiroaki Furumaki, MD, Toru Sakura, PhD MD, Yasunori Ueda, MD PhD, Masashi Sawa, MD PhD, Nobuaki Dobashi, MD, Rikio Suzuki, MD PhD, Yasuhiro Taniguchi, MD, Masaru Nakagawa, MD PhD, Shigehisa Tamaki, MD, Maki Hagihara, MD PhD, Katsumichi Fujimaki, MD, Yasuhisa Yokoyama, MD PhD, Hiroyuki Fujita, MD PhD, Masamitsu Yanada, MD PhD, Yoshinobu Maeda, MD PhD, Noriko Usui, MD PhD, Yukio Kobayashi, MD DSc, Hitoshi Kiyoi, MD PhD, Shigeki Ohtake, MD PhD, Itaru Matsumura, MD, Tomoki Naoe, MD PhD, Yasushi Miyazaki, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2798.
https://doi.org/10.1182/blood-2018-99-111638
Published: 2018
Journal Articles

Antitumor Activities Of An Oral Selective HSP90α/β Inhibitor, TAS-116, In Combination With Bortezomib In Multiple Myeloma

Rikio Suzuki, MD, PhD, Teru Hideshima, MD, PhD, Shuichi Ohkubo, PhD, Naoya Mimura, MD, PhD, Jiro Minami, MD, PhD, Hiroto Ohguchi, MD, PhD, Shohei Kikuchi, MD, PhD, Diana D. Cirstea, Francesca Cottini, MD, Dharminder Chauhan, PhD, Paul G. Richardson, MD, Nikhil C. Munshi, MD, Teruhiro Utsugi, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2013) 122 (21): 4429.
https://doi.org/10.1182/blood.V122.21.4429.4429
Published: 2013
Journal Articles

Preferential Hypermethylation of the DKK-1 Promoter in Core-Binding Factor Leukaemia.

Rikio Suzuki, MD, Makoto Onizuka, M.D., Minoru Kojima, M.D., Masako Shimada, M.D., Satomi Fukagawa, M.D., Kosuke Tsuboi, M.D., Hiroyuki Kobayashi, Ph.D, Ayumi Shintani, Ph.D, Yoshiaki Ogawa, Ph.D, Hiroshi Kawada, Ph.D, Tomomitsu Hotta, Ph.D, Kiyoshi Ando, Ph.D
Journal: Blood
Blood (2007) 110 (11): 4136.
https://doi.org/10.1182/blood.V110.11.4136.4136
Published: 2007